Eiger Biopharmaceuticals Inc (EIGR) has fallen Friday morning, with the stock falling -5.13% in pre-market trading to 1.11.
EIGR's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, EIGR ranks higher than 1% of stocks.
Eiger Biopharmaceuticals Inc has fallen 71.04% over the past month, closing at $4.45 on November 11. During this period of time, the stock fell as low as $1.17 and as high as $4.69. EIGR has an average analyst recommendation of Strong Buy. The company has an average price target of $32.00.
EIGR has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on EIGR!
Eiger Biopharmaceuticals Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, EIGR ranks better than 130% of stocks.
Important Dates for Investors in EIGR:
-Eiger Biopharmaceuticals Inc is set to release earnings on 2/1/2023. Over the last 12 months, the company has reported EPS of $-2.41.
-We do not have a set dividend date for Eiger Biopharmaceuticals Inc at this time.
Click Here To Get The Full Report on Eiger Biopharmaceuticals Inc (EIGR)
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter